364 related articles for article (PubMed ID: 23648302)
21. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
Zhou LX; Yan LN
Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
[TBL] [Abstract][Full Text] [Related]
23. Impact of hepatectomy for huge solitary hepatocellular carcinoma.
Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Yamamoto M
J Surg Oncol; 2013 Mar; 107(4):408-13. PubMed ID: 22903402
[TBL] [Abstract][Full Text] [Related]
24. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
25. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
26. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
[TBL] [Abstract][Full Text] [Related]
27. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; Polak WG; Verhoef C; Eskens FA; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN
Dig Surg; 2012; 29(6):522-8. PubMed ID: 23548745
[TBL] [Abstract][Full Text] [Related]
28. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Ikai I; Arii S; Kojiro M; Ichida T; Makuuchi M; Matsuyama Y; Nakanuma Y; Okita K; Omata M; Takayasu K; Yamaoka Y
Cancer; 2004 Aug; 101(4):796-802. PubMed ID: 15305412
[TBL] [Abstract][Full Text] [Related]
29. Selective main portal vein clamping to minimize the risk of recurrence after curative liver resection for hepatocellular carcinoma.
Yang Y; Fu SY; Lau WY; Lai ECh; Li AJ; Pan ZY; Zhou WP; Shen F; Wu MC
Hepatogastroenterology; 2012; 59(117):1560-5. PubMed ID: 22683973
[TBL] [Abstract][Full Text] [Related]
30. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein: the predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection.
Fan LF; Zhao WC; Yang N; Yang GS
Hepatogastroenterology; 2013 Jun; 60(124):825-36. PubMed ID: 23321029
[TBL] [Abstract][Full Text] [Related]
32. [Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy].
Zhao J; Yan T; Bi X; Zhao H; Huang Z; Zhou J; Li Z; Li C; Cai J
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):430-4. PubMed ID: 25241784
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
[TBL] [Abstract][Full Text] [Related]
34. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.
Nagasue N; Ono T; Yamanoi A; Kohno H; El-Assal ON; Taniura H; Uchida M
Br J Surg; 2001 Apr; 88(4):515-22. PubMed ID: 11298618
[TBL] [Abstract][Full Text] [Related]
36. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
37. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
38. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
39. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
